Project cooperation
BIOTECH: Finding a psychicatric pharmacology preclinical lab
We are seeking to collaborate with a partner that has in-vivo capabilities for psychitric models.
Founder & CEO
ReSynapse Therapeutics
Nes Ziona, Israel
Dr. Dorit Carmon is an entrepreneur with experience in 2X biotech companies. Dorit strategically grows early-stage startups.
Dr. Dorit Cohen Carmon is a neuroscientist and biotech entrepreneur with over a decade of experience founding and leading 2X biotech companies. She combines mechanism-based drug discovery to address critical gaps in mental health treatment.
As a strategic leader, Dorit integrates technology, business development, and legal aspects to drive the growth and profitability of early-stage startups across diverse therapeutic areas.
Her strong communication skills and creative mindset have helped foster valuable industry partnerships with venture capitalists and major pharmaceutical companies, leading to successful fundraising and deal closures.
Holding a Ph.D. from WIS, Dorit is dedicated to identifying novel scientific technologies and advancing them into effective patient therapies while maintaining a focus on milestone achievement and capital efficiency, all underpinned by her values of accountability, professionalism, and transparency.
Project cooperation
BIOTECH: Finding a psychicatric pharmacology preclinical lab
We are seeking to collaborate with a partner that has in-vivo capabilities for psychitric models.
Partnership
BIOTECH: Finding a strategic partner to develop novel psychitric drugs
We would like to find a strategic partner for co-funding and co-developing novel psychiatric drugs
Partnership
We would like to find potential strategic partnership for funding Novel Neuropsychiatric Drugs.